Janssen Robert's Insider Trades & SAST Disclosures
Janssen Robert's most recent trade in Dynavax Technologies Corp. was a trade of 11,904 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Janssen Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,904 | 81,526 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,904 | 23,806 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.93 per share. | 18 Feb 2025 | 4,041 | 77,485 (0%) | 0% | 12.9 | 52,250 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 55,000 | 55,000 | - | - | Stock Options (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,333 | 33,333 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 13,000 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,000 | 13,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 13,000 | 74,236 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.69 per share. | 13 Feb 2025 | 4,614 | 69,622 (0%) | 0% | 12.7 | 58,552 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,333 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,333 | 63,017 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 10 Feb 2025 | 1,781 | 61,236 (0%) | 0% | 13.2 | 23,509 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 35,710 | 35,710 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 4,333 | 4,333 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Janssen Robert | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 4,333 | 60,215 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. | 10 Feb 2024 | 1,531 | 58,684 (0%) | 0% | 12.8 | 19,627 | Common Stock |
| Dynavax Technologies Corp. | Janssen Robert | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 10,000 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Janssen Robert | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 10,000 | 59,925 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Janssen Robert | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.79 per share. | 03 Feb 2024 | 4,043 | 55,882 (0%) | 0% | 12.8 | 51,710 | Common Stock |
| Dynavax Technologies Corp. | Janssen Robert | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 1,500 | 38,673 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 04 Jan 2024 | 1,500 | 49,925 (0%) | 0% | 15 | 22,500 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 04 Jan 2024 | 1,500 | 51,425 (0%) | 0% | 9.4 | 14,115 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 24 Aug 2023 | 600 | 49,925 (0%) | 0% | 15.0 | 9,012 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2023 | 600 | 46,943 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 24 Aug 2023 | 600 | 50,525 (0%) | 0% | 9.4 | 5,646 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 23 Aug 2023 | 34,857 | 49,925 (0%) | 0% | 15.0 | 523,204 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 34,857 | 47,543 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 23 Aug 2023 | 34,857 | 84,782 (0%) | 0% | 9.4 | 328,004 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 08 Aug 2023 | 2,600 | 52,525 (0%) | 0% | 9.4 | 24,466 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 2,600 | 82,400 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 08 Aug 2023 | 2,600 | 49,925 (0%) | 0% | 15.1 | 39,130 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 10,000 | 50,753 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 10,000 | 10,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 6,250 | 42,767 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 4,334 | 51,706 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 4,334 | 8,666 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 3,381 | 47,372 (0%) | 0% | 10.4 | 35,027 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 2,014 | 40,753 (0%) | 0% | 10.4 | 20,865 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 1,781 | 49,925 (0%) | 0% | 10.4 | 18,451 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 9.73 per share. | 16 Feb 2023 | 514 | 36,517 (0%) | 0% | 9.7 | 5,001 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | SVP and CMO | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 16 Feb 2023 | 484 | 36,003 (0%) | 0% | 10.3 | 4,980 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 18,750 | 43,457 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 18,750 | 6,250 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 16.92 per share. | 08 Aug 2022 | 7,938 | 35,519 (0%) | 0% | 16.9 | 134,277 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 4,450 | 8,345 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 17.16 per share. | 05 Aug 2022 | 4,450 | 24,707 (0%) | 0% | 17.2 | 76,365 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 05 Aug 2022 | 4,450 | 29,157 (0%) | 0% | 10.5 | 46,592 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 900 | 12,795 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 05 Aug 2022 | 900 | 24,707 (0%) | 0% | 17.0 | 15,311 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 05 Aug 2022 | 900 | 25,607 (0%) | 0% | 10.5 | 9,423 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 30,000 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 30,000 | 38,276 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 13,000 | 13,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 17.07 per share. | 16 Nov 2021 | 53,431 | 8,276 (0%) | 0% | 17.1 | 912,292 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 53,431 | 13,695 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 16 Nov 2021 | 53,431 | 61,707 (0%) | 0% | 10.5 | 559,423 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 35,974 | 67,126 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 16 Nov 2021 | 35,974 | 44,250 (0%) | 0% | 10.5 | 376,648 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 17.16 per share. | 16 Nov 2021 | 35,974 | 8,276 (0%) | 0% | 17.2 | 617,479 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 900 | 103,100 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 01 Sep 2021 | 900 | 8,276 (0%) | 0% | 20.2 | 18,135 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 01 Sep 2021 | 900 | 9,176 (0%) | 0% | 10.5 | 9,423 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 2,917 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 16 Aug 2021 | 2,917 | 8,276 (0%) | 0% | 12.4 | 36,054 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.42 per share. | 16 Aug 2021 | 2,917 | 11,193 (0%) | 0% | 5.4 | 15,810 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 16 Aug 2021 | 1,415 | 8,276 (0%) | 0% | 3.4 | 4,799 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 11 Aug 2021 | 49,583 | 6,861 (0%) | 0% | 12.1 | 597,971 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 49,583 | 0 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.42 per share. | 11 Aug 2021 | 49,583 | 56,444 (0%) | 0% | 5.4 | 268,740 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 06 Aug 2021 | 80,000 | 6,861 (0%) | 0% | 10.8 | 860,000 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2021 | 1,000 | 86,861 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.64 per share. | 01 Feb 2021 | 42,155 | 86,485 (0%) | 0% | 10.6 | 448,529 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 17 Jul 2020 | 50,000 | 127,266 (0%) | 0% | 11.1 | 554,500 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 19 May 2020 | 15,000 | 177,266 (0%) | 0% | 6.3 | 94,950 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 05 May 2020 | 28,000 | 192,266 (0%) | 0% | 4.5 | 126,560 | Common Stock |
| Dynavax Technologies Corp. | Robert Janssen | Senior Vice President | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 05 May 2020 | 9,000 | 220,266 (0%) | 0% | 4.4 | 39,870 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges